Sweeping change needed amid ‘diabetes epidemic’: Inquiry The RACGP says prevention is key, as Medicare reform, bolstered rural access, sugar taxes, and CGM subsidies were all recommended.
PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.
Study links Ozempic to kidney failure prevention It found semaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution.
Replica Ozempic and Mounjaro to be banned The Government has removed a loophole allowing the mass production of the compounded drugs amid growing patient safety concerns.
Warning issued on point-of-care testing compliance Despite thousands of MBS claims, the DoHAC understands no clinics are approved for the HbA1c test, sparking calls for practices to get accredited.
Sydney home raided after Ozempic scam The TGA is urging GPs ‘exercise deep caution’ after doctors were faxed ads promoting allegedly illegally compounded semaglutide.
How RACGP Foundation seed funding blossomed into MRFF grant What started as a small, GP-led diabetes research project recently received close to $1 million to expand into other areas of chronic disease.
In Practice: Updates to allied health MBS items Referral changes to MBS items for Aboriginal and Torres Strait Islander patients accessing allied health services are now in place.
Pharmacy diabetes trial creating ‘serious concerns’ The RACGP has slammed a plan to screen for the disease in pharmacies, saying it could fragment care and put vulnerable patients at risk.
Funding needed to ‘help share the workload’: RACGP Commonwealth support should be funnelled into expanding general practices to include multidisciplinary care teams, according to a college submission.